Public companies now face threats they couldn't have imagined a decade ago. But AI is helping them fight back hard.
Hosted on MSN34m
Lilly's Zepbound approved by FDA for sleep apnea treatmentThe FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...
Eli Lilly (NYSE:LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback